Pathalys Pharma

A new path for patients with Chronic Kidney Disease

Raleigh, United States · $255.0M raised

Business Model
B2B
Total Funding
$255.0M
Last Round
$105.0M Series BAug 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Pathalys Pharma is a private, late-stage clinical biopharmaceutical company developing advanced therapeutics for people with late-stage chronic kidney disease. Its initial product candidate, upacicalcet, is an investigational intravenous calcimimetic for secondary hyperparathyroidism in patients receiving hemodialysis. The company was created to pursue multiple therapies that address unmet needs in end-stage kidney disease.

Summary

Pathalys Pharma is a Biotech company based in Raleigh, United States. It has raised $255.0M in total across 2 rounds, most recently a $105.0M Series B round in Aug 2024. Investors include Abingworth Bioventures, OrbiMed and J.P. Morgan Life Sciences Private Capital.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BAug 2024
$105.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Pathalys Pharma on Indexed.vc
<a href="https://indexed.vc/companies/pathalys-pharma"><img src="https://indexed.vc/api/badge/company/pathalys-pharma" alt="Pathalys Pharma on Indexed.vc" width="260" height="76" /></a>